Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Class 'A' Ordinary Shares
-
Shares outstanding
-
385,837,333
-
Total 13F shares
-
17,279,232
-
Share change
-
-1,256,328
-
Total reported value
-
$203,291,000
-
Price per share
-
$11.76
-
Number of holders
-
80
-
Value change
-
-$13,703,419
-
Number of buys
-
43
-
Number of sells
-
47
Institutional Holders of Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) as of Q4 2015
As of 31 Dec 2015,
Trinity Biotech plc - Class 'A' Ordinary Shares (TRIB) was held by
80 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
17,279,232 shares.
The largest 10 holders included
Boston Partners, JANUS CAPITAL MANAGEMENT LLC, Paradice Investment Management LLC, HEARTLAND ADVISORS INC, BANK OF MONTREAL /CAN/, ACK Asset Management LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, ROYCE & ASSOCIATES LLC, Senvest Management, LLC, and Lapides Asset Management, LLC.
This page lists
80
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.